Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects

Inclusion Criteria: * age: 20 - 55 years * body weight: standard weight(Broca's index, Possible range is plus or minus 20percent) * written informed consent Exclusion Criteria: * known allergy to Fimasartan * existing cardiac or hematological diseases * existing hepatic and renal diseases * existing gastrointestinal diseases * acute or chronic diseases which could affect drug absorption or metabolism history of any serious psychological disorder * abnormal diet which could affect drug absorption or metabolism * positive drug or alcohol screening * smokers of 10 or more cigarettes per day * participation in a clinical trial during the last 90 days prior to the start of the study